In our second episode on ALL we’ll be looking at adolescent and young adult (AYA) patients. Although these patients are commonly seen in the adult setting, evidence suggests that paediatric-inspired regimens may improve their outcomes. But how should these be implemented practically? Joining us this week is Dr Emily Curran, Assistant Professor in the Department of Medicine, Section of Hematology & Oncology at the UC College of Medicine.

Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.

References

- Malard F, Mohty M. Lancet 2020; 395(10230):1146-1162

- Moskoff B, et al. Blood 2016; 128(22):5195

- Huguet F, et al. J Clin Oncol. 2009; 27(6):911-8.

- Burke PW, et al. Leuk Res2018; 66:49-56

- Alacacioglu I, et al. Chemotherapy. 2014;60(4):219-23

- El-Cheikh J, et al. Clin Lymphoma Myeloma Leuk. 2017; 17(3):179-185

This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.